Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALPN | Common Stock | Exercise of in-the-money or at-the-money derivative security | $1.2K | +1.2M | +73.65% | $0.00* | 2.83M | Apr 25, 2024 | By: Frazier Life Sciences VIII, L.P. | F1 |
transaction | ALPN | Common Stock | Sale | -$1.23K | -19 | 0% | $64.57 | 2.83M | Apr 25, 2024 | By: Frazier Life Sciences VIII, L.P. | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALPN | Warrant (Right to Buy) | Exercise of in-the-money or at-the-money derivative security | $0 | -1.2M | -100% | $0.00* | 0 | Apr 25, 2024 | Common Stock | 1.2M | $0.00 | By: Frazier Life Sciences VIII, L.P. | F1, F3 |
Id | Content |
---|---|
F1 | The reportable securities are held directly by Frazier Life Sciences VIII, L.P. ("FLS LP"). FHM Life Sciences VIII, L.P. ("FHM LP") is the general partner of FLS LP. FHM Life Sciences VIII, L.L.C. ("FHM LLC") is the general partner of FHM LP. James N. Topper is one of two managing members of FHM LLC. Dr. Topper disclaims beneficial ownership of the securities held by FLS LP except for his pecuniary interest therein, if any. |
F2 | On April 25, 2024, Frazier Life Sciences VIII, L.P. exercised a warrant to purchase 1,200,000 shares of the Issuer's Common Stock at an exercise price of $0.001 per share. Frazier Life Sciences VIII, L.P. paid the exercise price on a cashless basis, resulting in the Issuer withholding 19 shares of Common Stock to pay the exercise price and issuing Frazier Life Sciences VIII, L.P. the remaining 1,199,981 shares of Common Stock. |
F3 | The warrant had no expiration date and was exercisable immediately. |